MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--VIVUS, Inc. (NASDAQ:VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products addressing obesity and sexual health, today announced that it will report financial results for the quarter and year ended December 31, 2006 before the NASDAQ Market opens on Friday, March 2, 2007. The Company will conduct a conference call and an audio webcast at 11:00 a.m. ET on the same day. In addition to a discussion of the financial results and accomplishments for 2006 the company will provide an update on the clinical activities for Qnexa, the company’s oral treatment for obesity.
